Financial statements Genomtec
Balance sheet data of GENOMTEC
|
Year
|
2018
|
2019
|
2020
|
|---|---|---|---|
| Total assets | 473 466,35 | 2 195 013,99 | 9 614 813,34 |
| A. Fixed assets | 40 125,00 | 426 899,83 | 1 682 225,80 |
| B. Current assets | 433 341,35 | 1 768 114,16 | 7 932 587,54 |
| C. Share capital contributions (basic funds) | - | - | 0,00 |
| D. Own shares (stocks) | - | - | 0,00 |
| Total liabilities | 473 466,35 | 2 195 013,99 | 9 614 813,34 |
| A. Equity | 432 372,96 | 941 467,46 | 7 789 466,40 |
| B. Liabilities and provisions for liabilities | 41 093,39 | 1 253 546,53 | 1 825 346,94 |
| I. Long-term liabilities | - | - | 537 045,90 |
| II. Short-term liabilities | - | - | 970 953,21 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.